Overview
- A federal lawsuit alleges Nutex worked with third‑party biller HaloMD to push ineligible claims through insurance arbitration, inflating reported results and misleading shareholders.
- Multiple firms, including Rosen Law Firm, Hagens Berman, Faruqi & Faruqi, and Levi & Korsinsky, are soliciting investors to participate and to move for lead‑plaintiff status.
- Notices cite a class period of Aug. 8, 2024 through Aug. 14, 2025 in describing the alleged misstatements and omissions.
- Nutex delayed its Q2 2025 Form 10‑Q on Aug. 14 and later disclosed its Audit Committee determined certain prior financial statements require restatement.
- The case follows a July 22 Blue Orca report citing insurer suits against HaloMD; Nutex publicly disputed those allegations and said it would provide updates in its filings.